Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Natasa Djordjevic. (2022) Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives. Expert Opinion on Drug Metabolism & Toxicology 18:12, pages 817-830.
Read now
Read now
Sébastien Landry, Jean-François Tanguay & Marie Lordkipanidzé. (2018) Personalizing antiplatelet therapies: What have we learned from recent trials?. Platelets 29:2, pages 131-139.
Read now
Read now
Fang Liu, Udaya S Tantry & Paul A Gurbel. (2015) P2Y12 receptor inhibitors for secondary prevention of ischemic stroke. Expert Opinion on Pharmacotherapy 16:8, pages 1149-1165.
Read now
Read now
Jean-Luc Reny & Pierre Fontana. (2015) Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?. Expert Opinion on Pharmacotherapy 16:4, pages 449-452.
Read now
Read now
Articles from other publishers (25)
Yu Fu, Xin-yi Zhang, Si-bei Qin, Xiao-yan Nie, Lu-wen Shi, Hong Shao & Jian Liu. (2020)
Cost–effectiveness of
CYP2C19
LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome
. Pharmacogenomics 21:1, pages 33-42.
Crossref
Crossref
Jesse Martin, Alexis K. Williams, Melissa D. Klein, Vindhya B. Sriramoju, Shivanshu Madan, Joseph S. Rossi, Megan Clarke, Jonathan D. Cicci, Larisa H. Cavallari, Karen E. Weck, George A. Stouffer & Craig R. Lee. (2019) Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting. Genetics in Medicine 22:1, pages 160-169.
Crossref
Crossref
PareshP Kulkarni & Debabrata Dash. (2019) Biochemical basis of novel antiplatelet drugs. Journal of Clinical and Scientific Research 8:4, pages 169.
Crossref
Crossref
Xiao-Fei Gao, Shu Lu, Zhen Ge, Guang-Feng Zuo, Zhi-Mei Wang, Feng Wang, Xiang-Quan Kong, Da-Yang Chai, Shao-Liang Chen & Jun-Jie Zhang. (2018) Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study. BMC Cardiovascular Disorders 18:1.
Crossref
Crossref
Ying Zhang, Xiao-juan Ma & Da-zhuo Shi. (2015) Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine. Chinese Journal of Integrative Medicine 24:8, pages 632-640.
Crossref
Crossref
Wahid Bouida, Kaouthar Beltaief, Houda Baccouche, Mouna Sassi, Zohra Dridi, Imen Trabelsi, Kamel Laaouiti, Taher Chakroun, Ilhem Hellara, Riadh Boukef, Nabil Sakly, Mohsen Hassine, Faouzi Added, Rabie Razgallah, Fadhel Najjar & Semir Nouira. (2018) Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients. PLOS ONE 13:3, pages e0192590.
Crossref
Crossref
Zhouling Xie, Lulu Zhao, Xue Ding, Yi Kong & Zhiyu Li. (2018) Design, synthesis and evaluation of 1,4-benzodioxine derivatives as novel platelet aggregation inhibitors. Future Medicinal Chemistry 10:4, pages 367-378.
Crossref
Crossref
W. Bouida, H. Baccouche, M. Sassi, Z. Dridi, T. Chakroun, I. Hellara, R. Boukef, M. Hassine, F. Added, R. Razgallah, I. Khochtali & S. Nouira. (2017) Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel. Thrombosis Journal 15:1.
Crossref
Crossref
Samah W. Al-Jabi. (2017) Global Trends in Aspirin Resistance-Related Research from 1990 to 2015: A Bibliometric Analysis. Basic & Clinical Pharmacology & Toxicology 121:6, pages 512-519.
Crossref
Crossref
Oscar Benimana, Lulu Zhao, Yi Kong, Zhiyu Li & Zhouling Xie. (2017) The progress in the research of antiplatelet agents (1995–2017). Future Medicinal Chemistry 9:10, pages 1087-1110.
Crossref
Crossref
Sivaprasad Sukavaneshvar. (2017) Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations. Advanced Drug Delivery Reviews 112, pages 24-34.
Crossref
Crossref
Minghuan Jiang & Joyce H. S. You. (2016) CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis. Cardiovascular Drugs and Therapy 31:1, pages 39-49.
Crossref
Crossref
Xumin Hou, Wenzheng Han, Qian Gan, Yuan Liu & Weiyi Fang. (2017) Relationship between thromboelastography and long-term ischemic events as gauged by the response to clopidogrel in patients undergoing elective percutaneous coronary intervention. BioScience Trends 11:2, pages 209-213.
Crossref
Crossref
Fan Zhang, Nosakhare Douglas Tongo, Victoria Hastings, Parisa Kanzali, Ziqiang Zhu, Hal Chadow & Shahrokh E. Rafii. (2017) ST-Segment Elevation Myocardial Infarction with Acute Stent Thrombosis Presenting as Intractable Hiccups: An Unusual Case. American Journal of Case Reports 18, pages 467-471.
Crossref
Crossref
M. Jakubowski, J. Dębski, E. Szahidewicz-Krupska, A. Turek-Jakubowska, J. Gawryś, K. Gawryś, R. Skomro, A. Derkacz & A. Doroszko. (2017) Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance. Oxidative Medicine and Cellular Longevity 2017, pages 1-8.
Crossref
Crossref
Zhouling Xie, Benimana Oscar, Lulu Zhao, Xue Ding, Chen Cao, Sen Feng, Han Li, Chen Pan, Ziyi Bian, Yang Li, Weijun Wang, Yi Kong & Zhiyu Li. (2017) Design, synthesis and evaluation of novel 2-amino-3-(naphth-2-yl)propanoic acid derivatives as potent inhibitors of platelet aggregation. European Journal of Medicinal Chemistry 125, pages 197-209.
Crossref
Crossref
E.A. Meyer, E. Caroff & M.A. Riederer. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
556
599
.
Jecko Thachil. (2016) Antiplatelet therapy – a summary for the general physicians. Clinical Medicine 16:2, pages 152-160.
Crossref
Crossref
A.Y. Mehta, B.M. Mohammed, E.J. Martin, D.F. Brophy, D. Gailani & U.R. Desai. (2016) Allosterism‐based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα‐binding and heparin‐binding site of thrombin. Journal of Thrombosis and Haemostasis 14:4, pages 828-838.
Crossref
Crossref
A. Komosa, J.M. Siller-Matula, M. Lesiak, M. Michalak, J. Kowal, M. Mączyński, A. Siniawski, T. Mularek-Kubzdela, S. Wiśniewski & S. Grajek. (2016) Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention. Thrombosis Research 138, pages 49-54.
Crossref
Crossref
Kevin P Bliden, Jeff Patrick, Andrew T Pennell, Udaya S Tantry & Paul A Gurbel. (2016) Drug delivery and therapeutic impact of extended-release acetylsalicylic acid. Future Cardiology 12:1, pages 45-58.
Crossref
Crossref
Eduardo Gonzalez, Ernest E. Moore & Hunter B. Moore. 2016. Trauma Induced Coagulopathy. Trauma Induced Coagulopathy
247
266
.
Erin? Akt?re, Andrew Goodwin & Bruce Tranmer. 2016. Anticoagulation and Hemostasis in Neurosurgery. Anticoagulation and Hemostasis in Neurosurgery
243
256
.
Eva Caroff, Francis Hubler, Emmanuel Meyer, Dorte Renneberg, Carmela Gnerre, Alexander Treiber, Markus Rey, Patrick Hess, Beat Steiner, Kurt Hilpert & Markus A. Riederer. (2015)
4-((
R
)-2-{[6-((
S
)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y
12
Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
. Journal of Medicinal Chemistry 58:23, pages 9133-9153.
Crossref
Crossref
Gerasimos Siasos, Evangelos Oikonomou, Marina Zaromitidou, Stamatios Kioufis, Eleni Kokkou, Konstantinos Mourouzis, Konstantinos Vlasis, Manolis Vavuranakis, Peter H. Stone, Athanasios G. Papavassiliou & Dimitris Tousoulis. (2015) Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy. Atherosclerosis 242:1, pages 102-108.
Crossref
Crossref